Evidence map›Paper›PMID 40236624›Full record

ArticleHealth care transitions2025

Clinical trials and young adults with inflammatory bowel disease.

Sneha Dave, Sydney Reed, Mara Shapiro, Yeabsira Taye, Isabela Hernandez, Navin Kariyawasam, Ildiko Mehes, Manasi Agrawal, Miguel Regueiro, Adam Faye and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health care transitions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sneha DaveGeneration Patient, United States.
Sydney ReedGeneration Patient, United States.
Mara ShapiroGeneration Patient, United States.
Yeabsira TayeCrohn's and Colitis Young Adults Network, United States.
Isabela HernandezGeneration Patient, United States.
Navin KariyawasamCrohn's and Colitis Young Adults Network, United States.
Ildiko MehesImprove Care Now, United States.
Manasi AgrawalIcahn School of The Susan and Leonard Feinstein IBD Center at Mount Sinai, United States.
Miguel RegueiroCleveland Clinic Lerner College of Medicine of Case Western Reserve University, United States.
Adam FayeCrohn's and Colitis Young Adults Network, United States.
Jeremy AdlerC.S. Mott Children's Hospital, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Young adults (approximately 18-35 years) with inflammatory bowel disease (IBD) represent a distinct demographic with unique developmental and physiological characteristics, yet they are underrepresented in clinical trials. This commentary synthesizes insights from a roundtable discussion facilitated by the Crohn's and Colitis Young Adults Network (CCYAN) between young adult patients with IBD and medical professionals, including physicians, nurses, psychologists, and trainees/medical students. Themes include defining young adults as a distinct demographic in research, improving outcomes for young adults with IBD through age-specific data disaggregation, barriers for participation and post-trial responsibilities, as well as regulatory and legislative policy opportunities to enhance young adult representation in clinical trials.

Indexed as

Adolescents in clinical trialsClinical trial diversityYoung adults in clinical trialsYoung adults with inflammatory bowel disease

Identifiers

PMID40236624
PMCPMC11997387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.